​

Prime Medicine Ownership | Who Owns Prime Medicine?

OverviewForecastRevenueFinancialsChart

Prime Medicine Ownership Summary

Prime Medicine is owned by 53.98% institutional investors, 23.91% insiders, and 22.11% retail investors. Massmutual trust co fsb/adv is the largest institutional shareholder, holding 0% of PRME shares. ARK Genomic Revolution ETF is the top mutual fund, with 1.86% of its assets in Prime Medicine shares.

PRME Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockPrime Medicine53.98%23.91%22.11%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Massmutual trust co fsb/adv---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Massmutual trust co fsb/adv---

Top Buyers

HolderShares% AssetsChange
Massmutual trust co fsb/adv---104.00

Top Sellers

HolderShares% AssetsChange
Massmutual trust co fsb/adv---104.00

Sold Out

HolderChange
Massmutual trust co fsb/adv-104.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202413211.86%64,335,371-6.37%531.64%7235.85%326.67%
Sep 30, 2024118-4.07%68,711,038-0.26%571.72%53-24.29%30-
Jun 30, 20241235.13%68,888,4713.34%571.42%7011.11%30-9.09%
Mar 31, 202411710.38%66,659,13737.23%632.24%6310.53%3317.86%
Dec 31, 202310626.19%48,574,438-1.90%531.84%5723.91%28100.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
ARK Genomic Revolution ETF2.45M1.86%94.29K
ARK Genomic Revolution2.41M1.84%-390.65K
ARK Disruptive Innovation Full Composite2.23M1.70%-237.53K
Vanguard US Total Market Shares ETF2.16M1.65%-
Vanguard Total Stock Mkt Idx Inv2.10M1.60%-
iShares Russell 2000 ETF1.49M1.14%-12.93K
Nikko AM ARK Disruptive Innovation A USD1.31M1.00%-11.68K
T. Rowe Price Small-Cap Value1.30M0.99%-
Nikko AM ARK Pstv Chg Innovt P JPY Acc1.29M0.98%-33.71K
US Small-Cap Growth II Equity Comp1.14M0.87%-984.00

Recent Insider Transactions

DateNameRoleActivityValue
Feb 15, 2024NELSEN ROBERT Buy$20.00M
Feb 15, 2024ARCH Venture Partners XII, LLC-Buy$20.00M
Feb 15, 2024ARCH Venture Partners X, LLC-Buy$20.00M
Jun 21, 2023GV 2019 GP, L.L.C.-Sell$284.50K
Jun 20, 2023GV 2019 GP, L.L.C.-Sell$563.25K

Insider Transactions Trends

DateBuySell
2024 Q4--
2024 Q2--
2024 Q13-
2023 Q4--
2023 Q3--

PRME Ownership FAQ

Who Owns Prime Medicine?

Prime Medicine shareholders are primarily institutional investors at 53.98%, followed by 23.91% insiders and 22.11% retail investors. The average institutional ownership in Prime Medicine's industry, Biotech Stocks , is 68.48%, which Prime Medicine falls below.

Does Blackrock own Prime Medicine?

BlackRock is not among the top 10 institutional shareholders of Prime Medicine.

Who is Prime Medicine’s biggest shareholder by percentage of total assets invested?

Massmutual trust co fsb/adv is Prime Medicine’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Prime Medicine shares, valued at 0$.

Who is the top mutual fund holder of Prime Medicine shares?

ARK Genomic Revolution ETF is the top mutual fund holder of Prime Medicine shares, with 1.86% of its total shares outstanding invested in 2.45M Prime Medicine shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools